Jiangsu Hansoh Pharmaceutical Group Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is MICAFUNGIN SODIUM, with a corresponding US DMF Number 33343.
Remarkably, this DMF maintains an Active status since its submission on December 14, 2018, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of March 06, 2019, and payment made on November 23, 2018, indicating their dedication to facilitating drug approvals, Categorized as Type II